G
Glenmark Pharmaceuticals
GLENMARK Share Price
Healthcare2,249.50
as on 17 Apr 2026 at 15:45
Market Cap
₹63,481 Cr
PE Ratio
59.60
ROCE
15.93%
GLENMARK Fundamentals
Company Valuation
Market Cap (₹ Cr.)
63,481
PE Ratio
59.60
PB Ratio
6.63
Dividend Yield
0.11%
ROE
11.83%
ROCE
15.93%
Book Value (₹)
339.54
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 46.65% | 46.65% | 46.65% | 46.65% | 46.65% |
| Domestic Institutional Investors (DII) | 14.60% | 17.64% | 18.61% | 20.09% | 19.29% |
| Foreign Institutional Investors (FII) | 23.16% | 20.62% | 20.73% | 19.20% | 20.34% |
| Public Investors | 12.32% | 11.69% | 10.81% | 10.77% | 10.32% |
| Government | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GLENMARK Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Midcap
BSE Scrip Code
532296
NSE Scrip Name
GLENMARK
ISIN
INE935A01035



